Navigation Links
Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
Date:3/14/2011

elieves," "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.  The company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to respond to the complete response letter regarding our new drug application for Linjeta™ in a timely manner and the possibility that information we provide in response to the letter may not be accepted by the FDA; our ability to secure FDA approval for Linjeta™ and our other product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel™ technology; the progress or success of our research, development and clinical programs and the initiation and completion of our clinical trials; the possibility that patients taking Linjeta™ may experience more injection site discomfort than they experience with competing products; unexpected data that may result from our clinical trials and our research and development activities; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilitie
'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
2. Biodel Inc. to Present at the Roth 23rd Annual OC Growth Stock Conference on March 16, 2011
3. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
4. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
5. Biodel Reports First Quarter Fiscal Year 2011 Financial Results
6. Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
7. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
8. Biodel Announces Retirement of Dr. Solomon Steiner as Chief Scientific Officer
9. Biodel Reports Fourth Quarter and Fiscal Year 2010 Financial Results
10. Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting
11. Biodel to Present Data from Product Development Programs at 2010 Diabetes Technology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2, 2014 , Elbit Imaging ... EMITF ) announced today following the Company,s announcement dated ... Medical") (TASE: EMTC-M), a subsidiary of the Company in ... basis, announced that on September 1, 2014 Gamida Cell ... the voting power ("Gamida Cell") and vast majority of ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 Cepheid ... Flu/RSV XC, an on-demand molecular test for ... Flu B, and differentiation of RSV infection. The ... under the European Directive on In Vitro ... of tests available to eighteen. Xpert Flu/RSV XC runs ...
(Date:9/2/2014)... New York , September 2, 2014 ... " Biological Drugs Market - Global Industry Analysis, ... is expected to grow at a CAGR of 10.1% ... typically derived from living cells and are used in ... cancer, blood-related diseases, auto-immune diseases and other medical disorders. ...
Breaking Medicine Technology:Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 2Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 2Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 3Cepheid Announces European Release of Xpert Flu/RSV XC for Accurate and Reliable Detection and Differentiation of Flu A, Flu B, and RSV Infection 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 3CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 5CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 6
... TECH ) announced that its Board of Directors has ... the quarter ended September 30, 2010.  The quarterly dividend will ... record on November 8, 2010.  Future cash dividends will be ... Techne Corporation has two operating subsidiaries:  Research and ...
... ALTO, Calif., Oct. 28 Jazz Pharmaceuticals, Inc. (Nasdaq: ... third quarter 2010 financial results on Thursday, November 4, 2010 ... will discuss its financial results and guidance for 2010, and ... and press release may be accessed from the Investors section ...
Cached Medicine Technology:
(Date:9/2/2014)... Durable Medical Goods manufacture ThermoTek , ... financing company LeaseQ, Inc. to help customers acquire capital ... 2012, LeaseQ’s breakthrough finance shopping platform has enabled businesses ... to run their business. , Said LeaseQ Vice ... ThermoTek sales team to provide customers faster access to ...
(Date:9/2/2014)... The American Healthcare Documentation Professionals Group (AHDPG) ... its ICD-10 Medical Coding Bridge Program. The purpose of ... confidence to students who are seeking to launch an ... with the uncertainty brought on by the federal government’s ... 1st, 2015. , AHDPG’s Free-Tuition Guarantee is simple and ...
(Date:9/2/2014)... News) -- The quality of Americans, diets has improved ... the rich and poor is growing, a new study ... to date that the extensive efforts by many groups ... some payoff, but it also indicates that these efforts ... doctoral student in the department of nutrition at the ...
(Date:9/2/2014)... By Amy Norton ... -- For people who want to lose weight and boost ... than trimming dietary fat, a new study suggests. In ... those assigned to follow a low-carbohydrate diet lost more weight ... They also had bigger improvements in their cholesterol and ...
(Date:9/2/2014)... PA (PRWEB) September 02, 2014 The ... Rehabilitation Hospital returns on September 19 at The ACE ... Pennsylvania. Over the past 25 years, the Classic, organized ... than $12 million for programs and services designed to ... Magee Rehabilitation Hospital. , “The Segal Classic is ...
Breaking Medicine News(10 mins):Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 2Health News:American Healthcare Documentation Professionals Group (AHDPG) Launches Free-Tuition Guarantee for Its ICD-10 Medical Coding Bridge Program 3Health News:Quality of U.S. Diet Improves, Slightly 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 2Health News:Low-Carb Beats Low-Fat for Weight Loss, Heart Health: Study 3Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2
... ... can now take advantage of its platform for rapid delivery of custom business applications. ,Formotus ... the first time today at the Mobile World Congress. Formotus demonstrated its mobile software in ... Barcelona, ...
... ... Georgia has become the company’s Vice President of Product Services. Among his responsibilities, Randy ... & Notification Network, White Pine’s flagship personal health record solution. , ... (PRWEB) February 14, 2010 -- ...
... ... Society of Aesthetic Plastic Surgery indicates a 162 percent increase in aesthetic ... continuing to rise, many men and women consider a tummy tuck (abdominoplasty) ... appropriate for their needs. At his practice offering plastic surgery in ...
... , ... Training and Consulting Inc., is bringing a unique approach to the Continuous Process Improvement ... one business strategy. , ... Denver, CO (PRWEB) February 15, 2010 -- Mountain Home Training and Consulting Inc., ...
... in the Feb. 15 issue of the Journal of ... and poor sleep quality significantly increase the risk of motor ... were twice as likely to have had a crash if ... or reported having bad sleep (OR = 1.9). Eighty ...
... might not be the best way to learn what to ... popular medical dramas and found that doctors and nurses on ... according to a study released today that will be presented ... Toronto April 10 to April 17, 2010. "Television dramas ...
Cached Medicine News:Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 2Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 3Health News:Formotus Announces Support for Mobile Business Forms on Android Phones 4Health News:Longtime Quality Assurance Executive Randy Johnson Joins White Pine Systems as Vice President of Product Services 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 2Health News:Is a Tummy Tuck Right for Me? Alabama Plastic Surgeon Dr. David Durst Offers Tips as the Popularity of Surgical Cosmetic Enhancement Continues to Rise 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 2Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 3Health News:Mountain Home 'Doing the Right Thing Really is the Best Business Approach' 4Health News:Sleep problems and sleepiness increase the risk of motor vehicle accidents in adolescents 2
... only powered 6-inch dermatome on the market. ... adult hands or a small child's face ... to run more efficiently, thus the motor ... temperature is much cooler. The Electro-Dermatome is ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Sinskey), blunt tip angled 45, 15.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles han...
Medicine Products: